#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital cystic kidney disease Fragile X syndrome Gastroenteropancreatic neuroendocrine tumour disease Neuropathy peripheral Ventricular tachycardia Mantle cell lymphoma stage IV Acquired C1 inhibitor deficiency Neuroendocrine tumour Hydrocephalus Chronic lymphocytic leukaemia Acute myeloid leukaemia (in remission) Chronic granulomatous disease Myasthenia gravis Ornithine transcarbamoylase deficiency Immune-mediated myasthenia gravis More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma Primary biliary cholangitis – Treatment Combined immunodeficiency – Treatment Anaplastic thyroid cancer – Basic Information Pelizaeus-Merzbacher disease – Basic Information Ewing’s sarcoma metastatic Haemophilia A with anti factor VIII – Basic Information Idiopathic pulmonary fibrosis Congenital hypotransferrinaemia – Treatment Small intestine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Piromelatine Avelumab Deferiprone Fexofenadine Hydrochloride Sodium Laurilsulfate Tioguanine PUCOTENLIMAB Enalapril Abrocitinib Erlotinib Tusamitamab Ravtansine Cldn6 Car-T(A) Phenylalanine Rbl027.2 Desloratadine Salbutamol Sulfate Ph. Eur. Atropine Sulfate Monohydrate Sodium Cromoglicate Rbl005.3 Cat Epithelium Extract More therapies…

    Learn about Your Condition

    Primary biliary cholangitis Penile cancer Status epilepticus Skin angiosarcoma Cardiac amyloidosis Pyoderma Oesophageal atresia Ulcerative keratitis Hyperhidrosis Testicular germ cell tumour Mite allergy Hepatorenal syndrome Developmental hip dysplasia Brain neoplasm T-cell type acute leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hippokration Hospital

Hippokration Hospital

Vassilissas Sofias Avenue 114, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cholestatic pruritus
    • Primary biliary cholangitis
    Investigated Drugs:
    • Linerixibat
    Belgium Bulgaria Czechia France Germany Greece +3

  • Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Belimumab
    France Germany Greece Italy Portugal Spain

  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Not recruiting

    1 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Golexanolone
    Germany Greece Hungary Italy Spain

  • Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Emapalumab
    • Sodium Chloride
    Greece

  • Study on Tulisokibart for Treating Moderate to Severe Crohn’s Disease in Adults

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Tulisokibart
    Austria Belgium Croatia Czechia Denmark Finland +15

  • Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Bulgaria France Greece Poland Romania

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

    Not recruiting

    3 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Croatia Czechia Estonia Germany Greece +8

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Amlodipine
    • Irbesartan
    Greece
Previous Page
1 … 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!